Nephros is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Robert Banks, with a market cap of $31.0M.
Common questions about Nephros
Nephros is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $5.0M.
Nephros has approximately 31 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.